Raymond James Financial Inc. purchased a new stake in Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 129,261 shares of the business services provider's stock, valued at approximately $5,552,000. Raymond James Financial Inc. owned 0.07% of Genpact as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in G. Vanguard Group Inc. lifted its holdings in shares of Genpact by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock valued at $728,539,000 after purchasing an additional 61,376 shares in the last quarter. Victory Capital Management Inc. increased its position in Genpact by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after buying an additional 1,511,790 shares in the last quarter. Franklin Resources Inc. raised its holdings in shares of Genpact by 1.3% in the fourth quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock worth $180,560,000 after acquiring an additional 55,771 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Genpact by 3.6% in the fourth quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock worth $170,175,000 after acquiring an additional 133,938 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Genpact by 8.7% in the fourth quarter. JPMorgan Chase & Co. now owns 3,400,636 shares of the business services provider's stock valued at $146,057,000 after acquiring an additional 271,295 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. The trade was a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.80% of the stock is owned by corporate insiders.
Genpact Price Performance
NYSE:G traded up $1.40 during trading hours on Wednesday, reaching $50.29. 1,528,519 shares of the company's stock were exchanged, compared to its average volume of 1,331,138. The business's 50-day simple moving average is $49.52 and its two-hundred day simple moving average is $46.51. The company has a market capitalization of $8.83 billion, a P/E ratio of 17.71, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Sell-side analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were paid a dividend of $0.17 per share. The ex-dividend date was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.35%. Genpact's dividend payout ratio (DPR) is 23.94%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on the company. Mizuho raised their price objective on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and increased their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their price target for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Needham & Company LLC boosted their price target on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $50.38.
Read Our Latest Analysis on Genpact
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report